Hi, what are you looking for?
Atox Bio will use the funds to support Phase 2 study for Acute Kidney Injury; Phase 3 study of Reltecimod for Necrotizing Soft Tissue...
– Atox Bio will conduct a Phase II study for a soft tissue infections treatment. Please help us out : Will you offer us...
Atox Bio, an Israeli a clinical stage biotechnology company, has been awarded a $24 million contract to fight flesh eating diseases. No, such diseases...
A new way to fight infection. The US Biomedical R&D Authority has awarded Israel’s Atox Bio $24 million to develop its treatments for severe infections. Atox...
– The conflict between Israel and Hamas is not causing Israeli businesses to hide out in the trenches. Rocket fire and negative media coverage...